AbCellera Biologics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ABCL | VERA | CLDX | ACRS | LGND | DNTH | |
|---|---|---|---|---|---|---|
| Market cap | 4.09B | 2.00B | 2.31B | 529.92M | 6.20B | 4.56B |
| P/E (TTM) | — | — | — | — | 32.8 | — |
| Forward P/E | -16.6 | -6.5 | -6.9 | -4.6 | 26.0 | -17.7 |
| Price/book | 4.3 | 4.9 | 3.2 | 4.0 | 6.4 | 3.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +122.84% | −2.00% | +10.17% | +88.48% | +67.77% | +139.31% |
| Today | +0.72% | −7.23% | −1.54% | −6.01% | +3.09% | −0.97% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ABCL news ›UBS Group Initiates Coverage on AbCellera Biologics (NASDAQ:ABCL)
Posted by Defense World Staff on Oct 12th, 2026 Research analysts at UBS Group assumed coverage on shares of AbCellera Biologics (NASDAQ:ABCL – Get Free Report) in a report released on Monday, Briefing.com reports. The brokerage set a…
Reviewing AbCellera Biologics (NASDAQ:ABCL) and Protagonist Therapeutics (NASDAQ:PTGX)
Posted by Defense World Staff on Oct 11th, 2026 Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) and AbCellera Biologics (NASDAQ:ABCL – Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We…
Surrozen (NASDAQ:SRZN) and AbCellera Biologics (NASDAQ:ABCL) Head-To-Head Contrast
Posted by Sarita Garza on Oct 7th, 2026 Surrozen (NASDAQ:SRZN – Get Free Report) and AbCellera Biologics (NASDAQ:ABCL – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses…
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause Society's (TMS) 2026 Annual Meeting, to be held October 20 to 24 at the Hilton Bayfront in San Diego, California.…
Assurant to announce Q3FY26 financial results on November 3
Assurant Inc. will release its third quarter 2026 financial results on Tuesday, November 3, 2026, after the market closes. The news release will be available on the company's website. In conjunction with the news release, Assurant will…
ABC board reports $40.5 million in sales; EMS update highlights push for local cath lab
High liquor sales, plans for additional ABC stores and the prospect of a long-sought heart catheterization lab in Davidson County were among the topics discussed Thursday morning by county officials. Lori Beck Clement, finance manager for…
EyeCool Therapeutics Appoints Dr. Richard Lindstrom to Board of Directors
EIN Presswire There were 2,412 press releases posted in the last 24 hours and 493,678 in the last 365 days. EyeCool Therapeutics Appoints Dr. Richard Lindstrom to Board of Directors Ruben F. Salinas, PhD EIN Presswire provides this news…
Haemonetics elects Martin Madaus to board of directors
Haemonetics Corporation has appointed Martin Madaus to its Board of Directors, effective July 24, 2026. Madaus, currently Senior Operating Executive at The Carlyle Group, brings over 30 years of experience in diagnostics and life sciences,…
JPMorgan Chase & Co. Begins Coverage on AbCellera Biologics (NASDAQ:ABCL)
JPMorgan Chase & Co. assumed coverage on shares of AbCellera Biologics (NASDAQ:ABCL – Get Free Report) in a report released on Tuesday, Briefing.com reports. The brokerage set an “overweight” rating and a $17.00 price target on the stock.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
defenseworld.net2
-
scanx.trade2
-
themarketsdaily.com2
-
biospace.com1
-
einpresswire.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.